Billy Amzal

2.1k total citations · 1 hit paper
49 papers, 1.2k citations indexed

About

Billy Amzal is a scholar working on Statistics and Probability, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Billy Amzal has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Statistics and Probability, 9 papers in Economics and Econometrics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Billy Amzal's work include Statistical Methods in Clinical Trials (11 papers), Renal cell carcinoma treatment (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Billy Amzal is often cited by papers focused on Statistical Methods in Clinical Trials (11 papers), Renal cell carcinoma treatment (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Billy Amzal collaborates with scholars based in France, Italy and United States. Billy Amzal's co-authors include Alicja Wolk, Bettina Julin, Agneta Åkesson, Marie Vahter, J.L.C.M. Dorne, Gunnar Johanson, Sandrine Micallef, Nelson Kinnersley, Satrajit Roychoudhury and Kert Viele and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and PLoS ONE.

In The Last Decade

Billy Amzal

44 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of historical control data for assessing treatment effects in clinical trials

2013 327 citations Billy Amzal, Sandrine Micallef et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Billy Amzal France	15	322	258	205	135	125	49	1.2k
Paul S. Price United States	25	1.0k 3.1×	57 0.2×	296 1.4×	38 0.3×	95 0.8×	66	1.7k
Dale Hattis United States	28	1.1k 3.5×	83 0.3×	141 0.7×	96 0.7×	350 2.8×	92	2.8k
Isao Yoshimura Japan	25	136 0.4×	203 0.8×	44 0.2×	47 0.3×	182 1.5×	131	2.3k
Bette Meek Canada	12	480 1.5×	24 0.1×	136 0.7×	34 0.3×	174 1.4×	18	1.2k
Lawrence I‐Kuei Lin United States	10	98 0.3×	159 0.6×	31 0.2×	23 0.2×	57 0.5×	15	957
Bruce D. Naumann United States	18	379 1.2×	20 0.1×	167 0.8×	33 0.2×	45 0.4×	34	940
Johanna E Camara United States	19	282 0.9×	75 0.3×	69 0.3×	11 0.1×	425 3.4×	42	1.5k
David P. Lovell United Kingdom	23	458 1.4×	54 0.2×	66 0.3×	30 0.2×	586 4.7×	74	2.0k
Annette M. Shipp United States	20	932 2.9×	34 0.1×	154 0.8×	25 0.2×	177 1.4×	29	1.7k
L. A. Thibodeau United States	12	149 0.5×	75 0.3×	17 0.1×	117 0.9×	133 1.1×	15	1.3k

Countries citing papers authored by Billy Amzal

Since Specialization

Citations

This map shows the geographic impact of Billy Amzal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Amzal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Amzal more than expected).

Fields of papers citing papers by Billy Amzal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billy Amzal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Amzal. The network helps show where Billy Amzal may publish in the future.

Co-authorship network of co-authors of Billy Amzal

This figure shows the co-authorship network connecting the top 25 collaborators of Billy Amzal. A scholar is included among the top collaborators of Billy Amzal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billy Amzal. Billy Amzal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Zhiheng, et al.. (2023). AI/ML in Precision Medicine: A Look Beyond the Hype. Therapeutic Innovation & Regulatory Science. 57(5). 957–962. 9 indexed citations

Quignot, Nadia, Witold Więcek, L.S. Lautz, J.L.C.M. Dorne, & Billy Amzal. (2020). Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment. Toxicology Letters. 337. 111–120. 5 indexed citations

Amzal, Billy, et al.. (2020). PND81 PREDICTION OF ALZHEIMER'S DISEASE (AD) FROM ASYMPTOMATIC STAGES USING MACHINE LEARNING (ML) MODELS. Value in Health. 23. S274–S274. 1 indexed citations

Zandvliet, Anthe S., Eva Gil Berglund, Billy Amzal, et al.. (2020). Artificial Intelligence and Machine Learning Applied at the Point of Care. Frontiers in Pharmacology. 11. 759–759. 60 indexed citations

Carnesecchi, Edoardo, Claus Svendsen, Nadia Quignot, et al.. (2019). Investigating combined toxicity of binary mixtures in bees: Meta-analysis of laboratory tests, modelling, mechanistic basis and implications for risk assessment. Environment International. 133(Pt B). 105256–105256. 70 indexed citations

Amzal, Billy, et al.. (2018). PHP42 - EARLY ACCESS PROGRAMS: A COMPARISON BETWEEN FRANCE, GERMANY AND THE UNITED KINGDOM. Value in Health. 21. S157–S157.

Quignot, Nadia, Witold Więcek, Billy Amzal, & J.L.C.M. Dorne. (2018). The Yin–Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment. Archives of Toxicology. 93(1). 107–119. 13 indexed citations

Amzal, Billy, Shuai Fu, Jie Meng, J. Lister, & Hélène Karcher. (2017). Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma. PLoS ONE. 12(9). e0184423–e0184423. 43 indexed citations

Nordon, Clémentine, Michel Aubier, Gabriel Thabut, et al.. (2016). The Burden of Severe Asthma in France. Value in Health. 19(7). A560–A561. 1 indexed citations

10.

Amzal, Billy & Fawzi Benzaghou. (2016). Bayesian Analysis Of Single Arm Trials: Concepts And Examples. Value in Health. 19(3). A100–A100.

11.

Sripan, Patumrat, Sophie Le Cœur, Billy Amzal, et al.. (2015). Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS ONE. 10(6). e0130917–e0130917. 1 indexed citations

12.

Lallemant, Marc, Billy Amzal, Saı̈k Urien, et al.. (2015). Antiretroviral intensification to prevent intrapartum HIV transmission in late comers. Journal of the International AIDS Society. 18. 20–21. 3 indexed citations

13.

Amzal, Billy, Emiliano Calvo, Xufang Wang, et al.. (2015). An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed. Clinical Therapeutics. 37(11). 2552–2559. 12 indexed citations

14.

Quignot, Nadia, et al.. (2015). Data collection on Combined Toxicity of Multiple Chemicals for Animal Health and Ecological Risk Assessment. EFSA Supporting Publications. 12(7). 6 indexed citations

15.

Aiassa, Elisa, Julian P. T. Higgins, Geoff K Frampton, et al.. (2014). Applicability and Feasibility of Systematic Review for Performing Evidence-Based Risk Assessment in Food and Feed Safety. Critical Reviews in Food Science and Nutrition. 55(7). 1026–1034. 39 indexed citations

16.

Voet, Hilko van der, J. N. Perry, Billy Amzal, & Claudia Paoletti. (2012). Response to: Comments on the paper "A statistical assessment of differences and equivalences between genetically modified and reference plant varieties. BMC Biotechnology. 12. 1 indexed citations

17.

Julin, Bettina, Marie Vahter, Billy Amzal, et al.. (2011). Relation between dietary cadmium intake and biomarkers of cadmium exposure in premenopausal women accounting for body iron stores. Environmental Health. 10(1). 105–105. 49 indexed citations

18.

Voet, Hilko van der, J. N. Perry, Billy Amzal, & Claudia Paoletti. (2011). A statistical assessment of differences and equivalences between genetically modified and reference plant varieties. BMC Biotechnology. 11(1). 15–15. 36 indexed citations

19.

Dorne, J.L.C.M., et al.. (2009). Combining analytical techniques, exposure assessment and biological effects for risk assessment of chemicals in food. TrAC Trends in Analytical Chemistry. 28(6). 695–707. 51 indexed citations

20.

Micallef, Sandrine, Billy Amzal, Véronique Bach, et al.. (2007). Sequential Updating of a New Dynamic Pharmacokinetic Model for Caffeine in Premature Neonates. Clinical Pharmacokinetics. 46(1). 59–74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact